Cohort study assessed the effect of antenatal cancer treatment on specific neonatal complications by type of chemotherapy and by type of cancer.
Recent use of hormonal contraception was associated with a higher risk of breast cancer than seen in women who had never used hormonal contraceptives, researchers found.
This fact sheet examines possible correlations between cancer risk and factors such as pregnancy and breast feeding.
Girls and women aged 39 years and younger may be up to 38% less likely to achieve pregnancy after surviving cancer vs patients who have never had cancer.
Cancer treatment during childbearing years increased risk of preterm birth and delivering low birth weight babies.
Increased risks among live births for adolescent and young adult cancer survivors
Pregnancy around the time of, or after, diagnosis of breast cancer is not associated with an increased risk of death.
Evidence suggests that women with myeloproliferative neoplasms have a higher risk of maternal and fetal complications. In this data analysis, researchers evaluated outcomes for pregnant women with essential thrombocythemia, polycythemia, or myelofibrosis and their infants.
Pregnancy screening rates before teratogenic exposures are low for female adolescent patients with acute leukemia and those with ER visits including abdominal/pelvic CT.
The BRCA1 mutation may speed the aging of a woman's ovaries,according to a recent report.
Among women aged up to 49 years with a pregnancy-associated melanoma, recurrence rates were higher than seen in other groups.
A recent study showed that women younger than 50 years who are pregnant or were recently pregnant at diagnosis of melanoma have a higher risk of death from the skin cancer.
Prenatal exposure to maternal cancer, with or without treatment, does not appear to impact early child development, a study found.
Women whose cancer is diagnosed while pregnant can start cancer treatment immediately and do not need to terminate the pregnancy.
The risk of hepatobiliary cancer and immune-mediated and cardiovascular diseases later in life is increased in women with intrahepatic cholestasis of pregnancy (ICP) than in women without this condition.
Abnormal findings on early test don't always indicate birth defects, researchers say, but could instead indicate cancer.
Embryo cryopreservation after aromatase inhibitor treatment and ovarian stimulation preserves fertility for patients with breast cancer, according to a study published online.
Non-invasive prenatal testing (NIPT) can be employed as a less-invasive means to detect cancer in expecting mothers.
Breast cancer during pregnancy presents additional psychosocial challenges as patients cope with a devastating diagnosis during a time of hope and promise for the future.
Female meningioma survivors are more likely to want and to become pregnant than the general population, and some research indicates that pregnancy may be a risk factor for tumor progression or recurrence.
Cause-specific mortality similar for women and girls with pregnancy-associated MM or non-PAMM.
This fact sheet examines the relationship between oral contraception and risk of breast, ovarian, endometrial, liver, and cervical cancers.
International team assessed the impact of cancer treatment on children of women pregnant at diagnosis or during treatmentOctober 15, 2014
A number of oncologists hesitate to administer treatments to pregnant patients with cancer, due to concerns about the effect on the unborn.
Use of fertility drugs doesn't appear to increase a woman's long-term risk of breast, ovarian, and uterine cancers, new research indicates, but researchers still urge long-term monitoring.
A new study has found that the levonorgestrel-releasing intrauterine system, or progesterone-releasing IUD, may be associated with a higher than expected incidence of breast cancer.
Increased odds for spontaneous abortions, stillbirths, and ectopic pregnancies were seen for smokers, compared to never-smoking women.
Fertility concerns are common among young women with newly diagnosed breast cancer, although only a minority pursue fertility preservation strategies.
Linear dose-response relationship for acute lymphoblastic leukemia and acute myeloid leukemia has been observed.
Risk the same as found in women in the general population with regard to oral contraceptive use.
Hemodynamic changes associated with pregnancy explain the growth of benign tumors in pregnant women. The study also identified some key characteristics associated with rapid growth of meningiomas in pregnant women.
Sign Up for Free e-newsletters
- Physical Inactivity Linked With Increased Risk of Hodgkin, Non-Hodgkin Lymphoma
- Challenges for Young Adult Couples Facing a Cancer Diagnosis
- Progression-Free Survival Extended With PANEX Protocol in R/R Multiple Myeloma
- Following ACS Guidelines Shown to Improve Outcomes for Colon Cancer Survivors
- National Cancer Drug Shortages Unknown to Many Patients
- Letter-Writing Project Communicates Care Wishes to Healthcare Team, Family
- Pivot Nurse Improves Patients' Navigation Through Lung Cancer Care
- Long-term Carfilzomib May Be Safe, Effective In Relapsed Multiple Myeloma
- Palliative Sedation a Valid Option for Refractory Symptoms in End-stage Cancer
- Testicular Cancer Treatment May Increase Risk for Heart Disease in Survivors
- Spotlight on Triptorelin in the Treatment of Premenopausal Women with Early-Stage Breast Cancer
- Redefining Prognosis for Hematologic Cancers in Older Adults by Age
- Outcomes for Elderly With Hematologic Cancers Effected by Cognitive Impairments
- Evolving Role of Radiation Therapy in the Treatment of Mesothelioma
- FDA Approves Fostamatinib for ITP After Insufficient Response to Previous Treatment
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|